A PTEN-Autophagy Risk Model for the Prediction of Prognosis and Immune Microenvironment in Hepatocellular Carcinoma

Figure 1

(a) The work flow of this study; (b) comparison of PTEN gene expression in tumor tissues (n = 360) and tumor-adjacent tissues (n = 50); (c) comparison of PTEN gene expression between samples with SNV mutation in PTEN (n = 8) and samples without SNV mutation (n = 352); (d) comparison of PTEN gene expression in different CNV groups including amplification (n = 3), diploid (n = 333), and deletion (n = 23); and (e) correlation analysis of PTEN gene expression and PTEN gene methylation.

(a)

(b)

(c)

(d)

(e)